LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 1 of total 1

Search options

Article ; Online: Impact of smoking on COVID-19 outcomes: a HOPE Registry subanalysis.

Espejo-Paeres, Carolina / Núñez-Gil, Iván J / Estrada, Vicente / Fernández-Pérez, Cristina / Uribe-Heredia, Giovanna / Cabré-Verdiell, Clara / Uribarri, Aitor / Romero, Rodolfo / García-Aguado, Marcos / Fernández-Rozas, Inmaculada / Becerra-Muñoz, Victor / Pepe, Martino / Cerrato, Enrico / Raposeiras-Roubín, Sergio / Barrionuevo-Ramos, María / Aveiga-Ligua, Freddy / Aguilar-Andrea, Carolina / Alfonso-Rodríguez, Emilio / Ugo, Fabrizio /
García-Prieto, Juan Fortunato / Feltes, Gisela / Akin, Ibrahim / Huang, Jia / Jativa, Jorge / Fernández-Ortiz, Antonio / Macaya, Carlos / Carrero-Fernández, Ana / Signes-Costa, Jaime

BMJ nutrition, prevention & health

2021  Volume 4, Issue 1, Page(s) 285–292

Abstract: Background: Smoking has been associated with poorer outcomes in relation to COVID-19. Smokers have ... Conclusion: Smoking has a negative prognostic impact on patients hospitalised with COVID-19. ... international registry Health Outcome Predictive Evaluation for COVID-19 (NCT04334291). Patients were included ...

Abstract Background: Smoking has been associated with poorer outcomes in relation to COVID-19. Smokers have higher risk of mortality and have a more severe clinical course. There is paucity of data available on this issue, and a definitive link between smoking and COVID-19 prognosis has yet to be established.
Methods: We included 5224 patients with COVID-19 with an available smoking history in a multicentre international registry Health Outcome Predictive Evaluation for COVID-19 (NCT04334291). Patients were included following an in-hospital admission with a COVID-19 diagnosis. We analysed the outcomes of patients with a current or prior history of smoking compared with the non-smoking group. The primary endpoint was all-cause in-hospital death.
Results: Finally, 5224 patients with COVID-19 with available smoking status were analysed. A total of 3983 (67.9%) patients were non-smokers, 934 (15.9%) were former smokers and 307 (5.2%) were active smokers. The median age was 66 years (IQR 52.0-77.0) and 58.6% were male. The most frequent comorbidities were hypertension (48.5%) and dyslipidaemia (33.0%). A relevant lung disease was present in 19.4%. In-hospital complications such sepsis (23.6%) and embolic events (4.3%) occurred more frequently in the smoker group (p<0.001 for both). All cause-death was higher among smokers (active or former smokers) compared with non-smokers (27.6 vs 18.4%, p<0.001). Following a multivariate analysis, current smoking was considered as an independent predictor of mortality (OR 1.77, 95% CI 1.11 to 2.82, p=0.017) and a combined endpoint of severe disease (OR 1.68, 95% CI 1.16 to 2.43, p=0.006).
Conclusion: Smoking has a negative prognostic impact on patients hospitalised with COVID-19.
Language English
Publishing date 2021-06-17
Publishing country England
Document type Journal Article
ISSN 2516-5542
ISSN (online) 2516-5542
DOI 10.1136/bmjnph-2021-000269
Database MEDical Literature Analysis and Retrieval System OnLINE

More links

Kategorien

To top